KR840008283A - 바이폰아졸 조성물의 제조방법 - Google Patents

바이폰아졸 조성물의 제조방법 Download PDF

Info

Publication number
KR840008283A
KR840008283A KR1019840001658A KR840001658A KR840008283A KR 840008283 A KR840008283 A KR 840008283A KR 1019840001658 A KR1019840001658 A KR 1019840001658A KR 840001658 A KR840001658 A KR 840001658A KR 840008283 A KR840008283 A KR 840008283A
Authority
KR
South Korea
Prior art keywords
composition
biponazole
diluent
imidazole
suitably
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019840001658A
Other languages
English (en)
Korean (ko)
Inventor
아담스 카를하인츠
Original Assignee
요아힘 그렘, 귄터 페터스
바이엘 아코티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요아힘 그렘, 귄터 페터스, 바이엘 아코티엔 게젤샤프트 filed Critical 요아힘 그렘, 귄터 페터스
Publication of KR840008283A publication Critical patent/KR840008283A/ko
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019840001658A 1983-03-30 1984-03-30 바이폰아졸 조성물의 제조방법 Ceased KR840008283A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833311700 DE3311700A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray
DEP3311700.4 1983-03-30

Publications (1)

Publication Number Publication Date
KR840008283A true KR840008283A (ko) 1984-12-14

Family

ID=6195161

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840001658A Ceased KR840008283A (ko) 1983-03-30 1984-03-30 바이폰아졸 조성물의 제조방법

Country Status (18)

Country Link
JP (1) JPS59184125A (enrdf_load_stackoverflow)
KR (1) KR840008283A (enrdf_load_stackoverflow)
AU (1) AU564979B2 (enrdf_load_stackoverflow)
BE (1) BE899277A (enrdf_load_stackoverflow)
CA (1) CA1212328A (enrdf_load_stackoverflow)
CH (1) CH660304A5 (enrdf_load_stackoverflow)
DE (1) DE3311700A1 (enrdf_load_stackoverflow)
ES (3) ES530845A0 (enrdf_load_stackoverflow)
FR (1) FR2543436B1 (enrdf_load_stackoverflow)
GB (1) GB2137090B (enrdf_load_stackoverflow)
GR (1) GR81880B (enrdf_load_stackoverflow)
IL (1) IL71363A0 (enrdf_load_stackoverflow)
IT (1) IT1173762B (enrdf_load_stackoverflow)
LU (1) LU85272A1 (enrdf_load_stackoverflow)
PH (1) PH20964A (enrdf_load_stackoverflow)
PT (1) PT78312B (enrdf_load_stackoverflow)
SE (1) SE8401747L (enrdf_load_stackoverflow)
ZA (1) ZA842336B (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
US5246716A (en) * 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
CN1084613C (zh) * 1995-12-14 2002-05-15 大正制药株式会社 气雾剂
RU2117473C1 (ru) * 1996-05-28 1998-08-20 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии МЗ и ПМ РФ Способ наружного лечения микозов стоп и гладкой кожи
WO2004000263A1 (en) * 2002-06-25 2003-12-31 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
CN118615240B (zh) * 2024-06-24 2024-12-27 江西普丽尔药业有限公司 一种联苯苄唑溶液剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
JPS6018655B2 (ja) * 1976-01-01 1985-05-11 バイエル・アクチエンゲゼルシヤフト アゾリル−(1)−メタン類及びそれらの塩
JPS5598112A (en) * 1979-01-17 1980-07-25 Sumitomo Chem Co Ltd Liquid medicine for external use
DE3019027A1 (de) * 1980-05-19 1981-11-26 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
CH660304A5 (de) 1987-04-15
ES8503946A1 (es) 1985-04-16
GB2137090B (en) 1986-07-09
IT1173762B (it) 1987-06-24
FR2543436B1 (fr) 1988-12-16
SE8401747L (sv) 1984-10-01
PT78312B (en) 1986-06-02
JPS59184125A (ja) 1984-10-19
BE899277A (fr) 1984-10-01
GB2137090A (en) 1984-10-03
ES8601691A1 (es) 1985-11-16
LU85272A1 (de) 1984-11-14
PH20964A (en) 1987-06-10
ES8601690A1 (es) 1985-11-16
PT78312A (en) 1984-04-01
ES539274A0 (es) 1985-11-16
ES530845A0 (es) 1985-04-16
ZA842336B (en) 1984-11-28
IT8420304A0 (it) 1984-03-29
ES539275A0 (es) 1985-11-16
IL71363A0 (en) 1984-06-29
GR81880B (enrdf_load_stackoverflow) 1984-12-12
AU564979B2 (en) 1987-09-03
SE8401747D0 (sv) 1984-03-29
CA1212328A (en) 1986-10-07
AU2623584A (en) 1984-10-04
FR2543436A1 (fr) 1984-10-05
GB8408066D0 (en) 1984-05-10
DE3311700A1 (de) 1984-10-04

Similar Documents

Publication Publication Date Title
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR840005718A (ko) 오메프라졸 중간체의 제조방법
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
KR830001269A (ko) 치환 프로린의 메르캅토 아실 유도체의 제조방법
KR850003414A (ko) (2-니트록시메틸-6-클로로피리딘)과 (β-사이클로덱스트린)의 교합화합물의 제조방법
KR910018350A (ko) 트리아릴설포늄 헥사플루오로메탈 또는 메탈로이드염의 제조방법
EP0376154A3 (de) Bisindenyl-Derivat und Verfahren zu seiner Herstellung
KR830009084A (ko) 퀴놀린 카복실산 유도체의 제조방법
KR870000103A (ko) 산화촉매의 제조방법
KR850008678A (ko) 2-아미노-3-에톡시카보닐아미노-6-cP-플루오로-벤질아미노)-피리딘 글루코노이트의 제조방법
KR840008283A (ko) 바이폰아졸 조성물의 제조방법
KR860008144A (ko) 1,3- 디알킬 -2- 이미다졸리디논의 제조방법
ES8207527A1 (es) Un metodo de preparacion de derivados de imidazolidinonas
KR840008284A (ko) 바이픈아졸 조성물의 제조방법
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
KR880000411A (ko) 벤조구아나민 유도체의 제법
KR850001185A (ko) 프로판-2-올 유도체의 제조방법
KR840007588A (ko) 트리아졸 항진균제의 제조방법
KR830001239A (ko) 할로겐화된 1-아조릴-1-플루오로페녹시-부탄유도체의 제조방법
KR840007422A (ko) 디아조 화합물의 제조방법
KR830000669A (ko) 알파-브로모프로 피온산의 신규혼합 마그네슘 할라이드 착화합물의 제조방법
KR840008335A (ko) 살충제의 제조방법
KR840005318A (ko) 살균제 조성물
KR930009998A (ko) N-(2-클로로-피리딘-5-일-메틸)-에틸렌디아민의 제조방법
SU730782A1 (ru) Клей дл изготовлени древесностружечных плит

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19840330

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19890224

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19840330

Comment text: Patent Application

PG1605 Publication of application before grant of patent
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19910604

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19910916

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19910604

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I